Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels: Another Piece of the Puzzle.

Martine Paquette, Alexis Baass

Journal: Circulation. Genomic and precision medicine 2019;11(5):e002165

PMID: 29748320

Abstract

Address: Nutrition, Metabolism and Atherosclerosis Clinic, Institut de Recherches Cliniques de Montréal, QC, Canada (M.P., A.B.).; Nutrition, Metabolism and Atherosclerosis Clinic, Institut de Recherches Cliniques de Montréal, QC, Canada (M.P., A.B.) [email protected].; Divisions of Experimental Medicine and Medical Biochemistry, Department of Medicine, McGill University, Montreal, QC, Canada (A.B.).

DOI: 10.1161/CIRCGEN.118.002165

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/29748320

Miscellaneous:

https://assays.cancer.gov/non-CPTAC-3369

Subscription / membership required

Full Text Sources:

https://www.ahajournals.org/doi/10.1161/CIRCGEN.11...
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Phenotype, Proprotein Convertase 9, Proprotein Convertases, Subtilisins